Form 8-K - Current report:
SEC Accession No. 0001140361-25-021440
Filing Date
2025-06-04
Accepted
2025-06-04 17:25:46
Documents
12
Period of Report
2025-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ef20050181_8k.htm   iXBRL 8-K 42583
  Complete submission text file 0001140361-25-021440.txt   170153

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adma-20250604.xsd EX-101.SCH 3880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20250604_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20250604_pre.xml EX-101.PRE 16054
14 EXTRACTED XBRL INSTANCE DOCUMENT ef20050181_8k_htm.xml XML 4059
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 251024185
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)